Unusual volume stocks are being observed in Wednesday's session.
By Mill Chart
Last update: May 1, 2024
The trading volume of these stocks is deviating from the norm in today's session.
Today's unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| CYCC | 26.42% | CYCLACEL PHARMACEUTICALS INC (NASDAQ:CYCC) has an unusual volume of 4.6M shares. Leading to a price increase of 26.42%. With an average daily volume of 572.02K over the past 50 days, today's volume is 704.0% above the average, indicating a potential shift in market sentiment. A press release (Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules) was released yesterday. |
| CSSE | 14.5% | The stock of CHICKEN SOUP FOR THE SOUL EN (NASDAQ:CSSE) has caught attention with a significant volume of 6.88M shares today. Shares in NASDAQ:CSSE are on the rise, with a gain of 14.5% observed in today's trading session. Compared to the average daily volume of the past 50 days, the current volume is 22.39% above, suggesting an unusual level of trading activity. |
| CSSEL | 35.0% | Today, CHICKEN SOUP FOR THE SOUL-26 (NASDAQ:CSSEL) stands out with a high volume of 2.14M shares. The share price of NASDAQ:CSSEL increased by 35.0% today, reflecting positive market movement. The current trading volume is 968.0% above the average 50-day volume. This indicates a significant deviation from the average trading activity. |
| BMRA | 7.21% | 329.77K shares of BIOMERICA INC (NASDAQ:BMRA) exchanged hands today. The market is favoring NASDAQ:BMRA today, as its share price records a notable increase of 7.21%. The average volume measured over 50 days is 228.0K, so this is 44.64% above the average volume. |
| DCPH | 0.2% | DECIPHERA PHARMACEUTICALS IN (NASDAQ:DCPH) has an unusual volume of 2.31M shares. NASDAQ:DCPH is experiencing an advancement of 0.2% in its share price today. The average volume measured over 50 days is 1.59M, so this is 45.34% above the average volume. The company's earnings where released Yesterday. A press release (ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals) was released yesterday. |
| ANVS | 12.84% | ANNOVIS BIO (NYSE:ANVS) has an unusual volume of 770.57K shares today. The share price of NYSE:ANVS increased by 12.84% today, reflecting positive market movement. This volume is 60.04% above the average 50 day volume. |
| BRKHW | 0.0% | So far 290.35K shares of BURTECH ACQUISITION -CW23 (NASDAQ:BRKHW) have traded in today's session. With an average daily volume of 109.68K over the past 50 days, today's volume is 165.0% above the average, indicating a potential shift in market sentiment. |
| WGS | 19.92% | The trading volume of GENEDX HOLDINGS CORP (NASDAQ:WGS) today is 1.07M shares, which is considered unusual. The share price increased by 19.92%. The average daily volume over 50 days is 348.81K, so this is 207.0% above the average volume. A press release (GeneDx Reports First Quarter 2024 Financial Results and Business Highlights) was released two days ago. |
| NWGL | -4.27% | With 150.51K shares traded so far, NATURE WOOD GROUP LTD-SP ADR (NASDAQ:NWGL) is experiencing an unusual level of activity today. The share price decreased by 4.27%. The average daily volume over the past 50 days is 103.78K. Hence, the current volume is 45.03% above the average volume, indicating a deviation from the usual trading pattern. |
| GV | -26.92% | Today, VISIONARY HOLDINGS INC (NASDAQ:GV) stands out with a high volume of 664.72K shares. The price decline of 26.92% reflects a downward movement in NASDAQ:GV shares. Compared to the average daily volume of the past 50 days, the current volume is 434.0% above, suggesting an unusual level of trading activity. |
Our unusual volume stocks screener will show you the full list.
ANNOVIS BIO
NYSE:ANVS (5/17/2024, 7:04:00 PM)
After market: 8.3 -0.01 (-0.12%)8.31
+0.28 (+3.49%)
ANVS News
19 hours ago - Law Offices of Howard G. SmithINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
a day ago - Glancy Prongay & Murray LLPGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
2 days ago - Law Offices of Frank R. CruzThe Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
5 days ago - InvestorPlaceANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the first quarter of 2024.
5 days ago - Annovis Bio Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsMALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, provided updates from across the organization and announced first quarter financial results.
9 days ago - ChartmillWhat's going on in today's sessionTop movers analysis one hour before the close of the markets on 2024-05-09: top gainers and losers in today's session.
9 days ago - Annovis Bio Inc.Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseMALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company...
12 days ago - Annovis Bio Inc.Annovis Bio CEO Maria Maccecchini Issues Letter to StockholdersMALVERN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company...
17 days ago - ChartmillUnusual volume stocks are being observed in Wednesday's session.The trading volume of these stocks is deviating from the norm in today's session.
